suffered a setback when its ziritaxestat failed in the phase III ISABELA study in the lung scarring disease idiopathic pulmonary fibrosis (IPF). But other companies continue to see the potential ...
Maria L. Padilla, MD, Icahn School of Medicine at Mount Sinai, previews that experts will discuss critical management strategies for interstitial lung disease and idiopathic pulmonary fibrosis, ...
updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are ...
Specific variants of the melatonin receptor 1A gene are a potential genetic cause of idiopathic osteoporosis. Specific variants of the melatonin receptor 1A (MTNR1A) gene are a potential genetic ...
NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 billion from 2024-2028 ...
CAL101, an investigational therapy with the potential to treat pulmonary fibrosis, showed a favorable safety and pharmacological profile in a Phase 1 clinical trial, according to results announced by ...
To keep up to date with the latest Number 1s each week, sign up to our newsletter. Unsubscribe at any time.
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...
Lung Nodules Defined A solitary pulmonary nodule (SPN) is a round or oval area in the lung that's smaller than 3 cm (1.2 inches or less). Of all SPNs detected, 95% are benign. However, they can change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback